<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>myasthenic exacerbation &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/myasthenic-exacerbation/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Oct 2026 18:47:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>myasthenic exacerbation &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>US claims study links generalized myasthenia gravis exacerbations to higher healthcare use and costs</title>
		<link>https://bioengineer.org/us-claims-study-links-generalized-myasthenia-gravis-exacerbations-to-higher-healthcare-use-and-costs/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 20 Oct 2026 18:47:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[claims analysis]]></category>
		<category><![CDATA[crises]]></category>
		<category><![CDATA[exacerbations]]></category>
		<category><![CDATA[generalized]]></category>
		<category><![CDATA[generalized myasthenia gravis]]></category>
		<category><![CDATA[gravis]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[healthcare resource use]]></category>
		<category><![CDATA[myasthenia]]></category>
		<category><![CDATA[myasthenic crisis]]></category>
		<category><![CDATA[myasthenic exacerbation]]></category>
		<category><![CDATA[United States]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=441835</guid>

					<description><![CDATA[A retrospective US claims study found that adults with generalized myasthenia gravis who experienced an exacerbation or crisis had higher healthcare use and mean annual costs $70,792 above those without an event.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">441835</post-id>	</item>
	</channel>
</rss>
